CTI BioPharma Corp. (CTIC) financial statements (2022 and earlier)

Company profile

Business Address 3101 WESTERN AVENUE
SEATTLE, WA 98121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:655334672744128
Cash and cash equivalents654031362744128
Short-term investments 12331   
Other undisclosed cash, cash equivalents, and short-term investments 00(0)   
Restricted cash and investments    16  
Receivables    000
Inventory, net of allowances, customer advances and progress billings    123
Inventory    123
Other undisclosed current assets322153104
Total current assets:685436824756135
Noncurrent Assets
Property, plant and equipment0112234
Other noncurrent assets4396656
Total noncurrent assets:44117889
TOTAL ASSETS:725846905564144
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1791217163233
Accounts payable42 43711
Accrued liabilities1371213142522
Debt474550837
Deferred revenue and credits101
Other liabilities3421112
Total current liabilities:67171823194172
Noncurrent Liabilities
Long-term debt and lease obligation  49141119
Long-term debt, excluding current maturities  49141119
Liabilities, other than long-term debt2155645
Deferred revenue and credits011
Other liabilities2155544
Total noncurrent liabilities:211014201525
Total liabilities:69182837395697
Stockholders' equity
Stockholders' equity attributable to parent, including:4402459221352
Preferred stock    1  
Common stock0000   
Additional paid in capital2,4302,3682,2992,294   
Accumulated other comprehensive income (loss) 0(12)(11)(6)(7)(7)
Accumulated deficit(2,426)(2,328)(2,264)(2,225)(2,195)(2,150)(2,098)
Other undisclosed stockholders' equity attributable to parent    2,2222,1702,157
Stockholders' equity attributable to noncontrolling interest  (6)(6)(6)(6)(5)
Total stockholders' equity:440185316847
TOTAL LIABILITIES AND EQUITY:725846905564144

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1 326255716
Revenue, net255716
Sublease income1  
Cost of revenue  (1)(5)(0) (2)
Cost of goods and services sold   (1)(0) (2)
Gross profit:1 322255714
Operating expenses(95)(48)(43)(55)(64)(110)(131)
Other operating income, net     5 
Other undisclosed operating loss(1)    (1) 
Operating loss:(95)(48)(41)(33)(40)(49)(117)
Nonoperating income (expense)(3)(5)14(1)(4)(4)
Investment income, nonoperating (4)11   
Foreign currency transaction gain (loss), before tax (0)(0)(0)1(0)(1)
Other nonoperating income (expense)(0) 14(0)(0)(1)
Interest and debt expense(2)(1)(1)(1)(0)(3)(1)
Loss before gain (loss) on sale of properties:(100)(53)(41)(31)(41)(56)(122)
Other undisclosed net income 111031
Net loss:(100)(52)(40)(29)(41)(53)(121)
Net income attributable to noncontrolling interest  00011
Other undisclosed net income attributable to parent2      
Net loss attributable to parent:(98)(52)(40)(29)(41)(52)(119)
Preferred stock dividends and other adjustments   (0)(4) (3)
Net loss available to common stockholders, diluted:(98)(52)(40)(29)(45)(52)(123)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(100)(52)(40)(29)(41)(53)(121)
Other comprehensive income (loss)(0)0(1)(4)00(0)
Other undisclosed comprehensive income2      
Comprehensive loss:(98)(52)(41)(34)(40)(53)(121)
Comprehensive income, net of tax, attributable to noncontrolling interest  00011
Comprehensive loss, net of tax, attributable to parent:(98)(52)(41)(34)(40)(52)(120)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: